
    
      This study consist of 2 designs. First is in vitro study to investigate the effect of
      alfacalcidol supplementation to IL-6, IL-10 and IFN gamma regulation in Peripheral Blood
      Mononuclear Cells (PBMC) of elderly and second design is randomised controlled trial to
      evaluate the effect of 3 months supplementation of alfacalcidol 0,5 mcg in respiratory
      infection, antibiotic use, inflammatory markers, CD4/CD8 ratio and CD8+ CD28+ in Indonesian
      elderly with various level of frailty syndrome.
    
  